Description: PanGen Biotech Inc. operates as a specialized biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as distributes polysciences products. The company was founded in 1999 and is based in Suwon, South Korea.
Home Page: www.pangen.com
Innoplex 2-dong
Suwon,
16675
South Korea
Phone:
82 3 1733 9165
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 13.3485 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |